0.44
0.44 (0%)
As of Feb 14, 2025
Genprex, Inc. [GNPX]
Source:
Company Overview
Genprex, Inc. is a clinical stage gene therapy company pioneering the development of gene-based therapies for large patient populations with unmet medical needs.
| Country | United States |
| Headquarters | austin, texas |
| Phone Number | 512-537-7997 |
| Industry | manufacturing |
| CEO | Genprex, Inc. |
| Website | genprex.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $0 |
| Operating Profit | $-21.2 |
| Net Income | $-21.1 |
| Net Cash | $-5.1 |
Profit Ratios
| Gross Margin | $0 |
| Operating Margin | |
| Profit as % of Revenues | |
| Profit as % of Assets | -285.4% |
| Profit as % of Stockholder Equity | -1,303% |
Management Effectiveness
| Return on Equity | -1,303% |
| Return on Assets | -511.9% |
| Turnover Ratio | |
| EBITA | $-21.2 |
Balance Sheet and Cash Flow Measures
| Total Assets | $4.1 |
| Total Liabilities | $2.5 |
| Operating Cash Flow | $-17.1 |
| Investing Cash Flow | $0 |
| Financing Cash Flow | $12 |
